Mursla Bio Accelerates US Commercial Deployment of EvoLiver Through ABHI Programme

Mursla Bio, a leader in Extracellular Vesicle (EV) science on a mission to significantly improve chronic disease outcomes for ...

Cancer campaigner and ex-wife of Olympic legend dies at 48

Jackie Robertson, 48, was holding her mother Sharon Robertson’s hand on Saturday morning as she died peacefully at Waikato ...

Injectable 'satellite livers' could offer an alternative to liver transplantation

More than 10,000 Americans who suffer from chronic liver disease are on a waitlist for a liver transplant, but there are not ...

I Was Diagnosed with Stage 4 Colorectal Cancer at 26 (Exclusive)

David Lyon, now 31, was diagnosed with stage 4 colon cancer at 26. For March's Colorectal Cancer Awareness Month, he's urging ...

A Look at the Life-Saving Advances to Fight Colorectal Cancer

Colorectal cancer is the fourth most commonly diagnosed cancer in the United States and the second leading cause of cancer ...
Drug Target Review

Blocking growth hormone may improve resistant lung cancer treatment

Explore new strategies for treating resistant lung cancer. Discover how blocking growth hormone receptors may improve ...
CNA

Rahayu Mahzam on screening for lung, liver cancer

Under HealthierSg, regular screening for common cancers such as breast, cervical and colorectal cancer is recommended and ...

Hepion Pharmaceuticals In-Licenses ctRNA Biomarker Assay to Facilitate Early Diagnosis and Surveillance of Hepatocellular Carcinoma

Next-generation, non-invasive diagnostic platform has potential applications in solid tumor types beyond liver cancer Licensing deal reflects Hepion’s strategic shift to advancing clinically proven ...